Research suggests abnormal levels of Sac3 may precipitate Parkinson’s disease and hold key to future therapies.
Browsing: Cognitive/neurodegenerative disorders
A new study has highlighted the importance of immune system research in fighting Alzheimer’s disease.
Deborah Gustafson (State University of New York—Downstate Medical Center, NY, USA & University of Gothenburg, Sweden) discusses the complex relationship between BMI and dementia and evaluates the current literature within the epidemiological literature.
New research has uncovered the key mechanism behind the interaction between small heat shock proteins and other proteins key in the development of neurodegenerative diseases.
This editorial explores nonpharmacological treatment options for psychosis in Parkinson’s disease, drawing lessons from pre-existing dementia and schizophrenia literature.
Neurology Central talks to Johan Vos, Deputy Executive Director of Alzheimer’s Disease International about the charity’s work and the key findings of the 2015 World Alzheimer Report.
Neurology Central finds out more about ARUK and the key projects they are funding for Alzheimer’s disease research.
International experts call for changes in the treatment and management of Multiple Sclerosis at ECTRIMS.
The propensity of a protein to form amyloid assemblies is imprinted in its sequence and can be read using computational approaches. This article utilizes four different algorithms to analyze the presence of aggregation-prone regions in the sequence and structure of neuroreceptors.
Preclinical study demonstrates that multiple sclerosis nerve repair could be initiated by partial blockade of a cancer-promoting pathway, providing new hope for therapeutics.